Nov 14 (Reuters) - Factor Therapeutics Ltd FTT.AX :
* PHASE 2 TRIAL OF VF001 FOR TREATMENT OF VENOUS LEG ULCER FAILED TO MEET ALL ENDPOINTS
* ONGOING DEVELOPMENT OF VF001 FOR ALL INDICATIONS HALTED
* ROSALIND WILSON WILL STEP DOWN AS CEO IN DUE COURSE
* TO LIMIT FURTHER ACTIVITY TO MAINTAINING EXISTING INTELLECTUAL PROPERTY PORTFOLIO